Cogent Biosciences Inc (NASDAQ:COGT) price on Thursday, April 10, fall -9.87% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $4.02.
A look at the stock’s price movement, the close in the last trading session was $4.46, moving within a range at $3.885 and $4.33. The beta value (5-Year monthly) was 0.196. Turning to its 52-week performance, $12.61 and $3.72 were the 52-week high and 52-week low respectively. Overall, COGT moved -47.04% over the past month.
Cogent Biosciences Inc’s market cap currently stands at around $457.68 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-24.
Turning to the stock’s technical picture we see that short term indicators suggest on average that COGT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend COGT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
COGT’s current price about -34.25% and -44.43% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 23.58, while 7-day volatility ratio is 17.08% and 8.96% in the 30-day chart. Further, Cogent Biosciences Inc (COGT) has a beta value of 1.97, and an average true range (ATR) of 0.55. Analysts have given the company’s stock an average 52-week price target of $14, forecast between a low of $14 and high of $14. Looking at the price targets, the low is -248.26% off current price level while to achieve the yearly target high, price needs to move -248.26%. Nonetheless, investors will most likely welcome a -248.26% jump to $14 which is the analysts’ median price.
If we refocus on Cogent Biosciences Inc (NASDAQ:COGT), historical trading data shows that trading volumes averaged 1.94 over the past 10 days and 1.45 million over the past 3 months. The company’s latest data on shares outstanding shows there are 110.46 million shares.
The 16.22% of Cogent Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 91.51% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.84 million on 2025-03-14, giving us a short ratio of 9.77. The data shows that as of 2025-03-14 short interest in Cogent Biosciences Inc (COGT) stood at 1147.00004 of shares outstanding, with shares short rising to 10.8 million registered in 2025-02-14. Current price change has pushed the stock -48.46% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the COGT stock continues to rise going into the next quarter.
